Pei-Ying Wu

6PUBLICATIONS
8CO-AUTHORS
Medical infection agents (incl. prions)Psychosocial aspects of childbirth and perinatal mental healthSolid tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 28, 2024
Tissue Inhibitor of Metalloproteinase 3: Unravelling Its Biological Function and Significance in Oncology.

Wei-Ting Lee, Pei-Ying Wu, Ya-Min Cheng

|Jan 11, 2024
Downregulation of Salt-Inducible Kinase 3 Enhances CCL24 Activation in the Placental Environment with Preeclampsia.

Hsing-Fen Tsai, Ching-Fen Tseng, Yu-Ling Liang

|Apr 07, 2022
A case report of appendiceal adenocarcinoma without gastrointestinal evidence mimicking primary ovarian cancer.

Chih-Wei Lin, Shu-Ling Peng, Shu-Hsien Wang

|Dec 24, 2021
miR-335 Restrains the Aggressive Phenotypes of Ovarian Cancer Cells by Inhibiting COL11A1.

Yi-Hui Wu, Yu-Fang Huang, Tzu-Hao Chang

|Oct 22, 2021
Omental Macrophagic "Crown-like Structures" Are Associated with Poor Prognosis in Advanced-Stage Serous Ovarian Cancer.

Yu-Ling Liang, Chang-Ni Lin, Hsing-Fen Tsai

|Aug 27, 2021
MET Mutation Is a Potential Therapeutic Target for Advanced Endometrial Cancer.

Yu-Min Yeh, Pei-Ying Wu, Peng-Chan Lin

Pageof 1